Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Schuler

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2005
[Therapeutic application of TNF-alpha inhibitors infliximab and etanercept in inflammatory skin disorders]Arnd Jacobi, Bernhard Manger, Gerold Schuler, et al.
Current Opinion in Immunology|March 14, 2003
The use of dendritic cells in cancer immunotherapyGerold Schuler, Beatrice Schuler-Thurner, Ralph M Steinman
Immunotherapy|January 28, 2017
Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapyAlvaro Moreira, Waltraud Leisgang, Gerold Schuler, et al.
Immunology|June 11, 2005
Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cellsDetlef Dieckmann, Heidi Plöttner, Stefanie Dotterweich, et al.
Experimental Dermatology|June 2, 2016
Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanomaUgur Uslu, Gerold Schuler, Jan Dörrie, et al.
International Journal of Dermatology|May 7, 2009
Erosive pustular dermatosis of the leg in a patient with ankylosing spondylitis: neutrophilic dysfunction as a common etiological factor?Michael Erdmann, Franklin Kiesewetter, Gerold Schuler, et al.
International Journal of Molecular Sciences|June 15, 2019
CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor LeukemiaDennis C Harrer, Gerold Schuler, Jan Dörrie, et al.
Journal of Cutaneous Medicine and Surgery|June 21, 2012
Successful treatment of pyoderma gangrenosum with intravenous immunoglobulins during pregnancyCornelia Erfurt-Berge, Christine Herbst, Gerold Schuler, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2016
Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanomaMichael C Kirchberger, Axel Hauschild, Gerold Schuler, et al.
European Journal of Dermatology : EJD|August 29, 2006
Topical imiquimod as treatment for different kinds of cutaneous lymphomaEsther A Coors, Gerold Schuler, Peter Von Den Driesch
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2005
[Therapeutic application of TNF-alpha inhibitors infliximab and etanercept in inflammatory skin disorders]Arnd Jacobi, Bernhard Manger, Gerold Schuler, et al.
Current Opinion in Immunology|March 14, 2003
The use of dendritic cells in cancer immunotherapyGerold Schuler, Beatrice Schuler-Thurner, Ralph M Steinman
Immunotherapy|January 28, 2017
Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapyAlvaro Moreira, Waltraud Leisgang, Gerold Schuler, et al.
Immunology|June 11, 2005
Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cellsDetlef Dieckmann, Heidi Plöttner, Stefanie Dotterweich, et al.
Experimental Dermatology|June 2, 2016
Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanomaUgur Uslu, Gerold Schuler, Jan Dörrie, et al.
International Journal of Dermatology|May 7, 2009
Erosive pustular dermatosis of the leg in a patient with ankylosing spondylitis: neutrophilic dysfunction as a common etiological factor?Michael Erdmann, Franklin Kiesewetter, Gerold Schuler, et al.
International Journal of Molecular Sciences|June 15, 2019
CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor LeukemiaDennis C Harrer, Gerold Schuler, Jan Dörrie, et al.
Journal of Cutaneous Medicine and Surgery|June 21, 2012
Successful treatment of pyoderma gangrenosum with intravenous immunoglobulins during pregnancyCornelia Erfurt-Berge, Christine Herbst, Gerold Schuler, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2016
Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanomaMichael C Kirchberger, Axel Hauschild, Gerold Schuler, et al.
European Journal of Dermatology : EJD|August 29, 2006
Topical imiquimod as treatment for different kinds of cutaneous lymphomaEsther A Coors, Gerold Schuler, Peter Von Den Driesch
Pageof 19